A welcome from our CEO
Dr Che Connon
Chief Executive Officer, BSF Enterprise PLC
Welcome to BSF Enterprise’s investor website, and thank you for your interest in what we are building.
Our aim is to grow high-quality tissue and materials from cells, as an alternative to sources that today depend on animals or human donors.
At the heart of the Group is 3D Bio-Tissues, our research and IP company in Newcastle upon Tyne. Its tissue-engineering platform uses macromolecular crowding to help cells lay down their own natural matrix.
From that platform, our companies are taking the technology into several markets: leather for luxury fashion and automotive interiors through Lab-Grown Leather, corneal repair through Kerato, and cell-culture media supplements through milieu.bio. ETSYL®, our collagen-stimulating peptide, is licensed for skincare. 3D Bio-Tissues has also filed a patent application for seamless tissue coverings for humanoid robot hands.
This site is built for our shareholders and anyone considering investing. You can read every announcement, watch updates from the team and ask questions on any piece of news. Please do send yours. My team and I read them all and will reply wherever we can.
Exploring cell-grown skin for robots
Robots are getting smarter and more agile, but they still meet the world through their outer surface. 3D Bio-Tissues is exploring whether its cell-grown tissue could give robot makers an alternative to the synthetic coverings they use today.
Today
Synthetic elastomers
Silicones, polyurethanes and synthetic rubbers cover most humanoid and autonomous robots. In continuous use they can wear and degrade, especially at the joints.
What we are exploring
Cell-grown tissue
3DBT’s platform grows tissue from cells, which lay down their own natural matrix. The research question is whether its natural flexibility can hold up better where synthetic coverings are under most strain.
